Close Menu

NEW YORK — Mologic said on Monday that it has signed an agreement for the manufacture of its ELISA-based SARS-CoV-2 test with Omega Diagnostics.

Under the material transfer agreement between the UK-based companies, Omega will immediately begin manufacturing the lab-based test. Mologic said it will offer the test in the UK, as well as in Africa through an alliance with the Institut Pasteur de Dakar in Senegal, with access prioritized for health services and key worker communities.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

This webinar will present a case study from in vitro diagnostics developer SpeeDx on its experience building a complete sample-to-result workflow — encompassing instrumentation and data analysis software — for its qPCR-based ResistancePlus MG Mycoplasma genitalium assay.

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.